Advertisement

Aging, Comorbidity, and Breast Cancer Survival: An Epidemiologic View

  • William A. Satariano
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 330)

Abstract

This is a review of epidemiologic studies, which suggest that comorbidity (e.g., diabetes and heart disease) has an adverse effect on survival among women with incident, invasive breast cancer, adjusting for chronological age and stage of breast cancer at diagnosis. As part of this review, recent results are presented from a series of 463 breast cancer cases, identified through the Metropolitan Detroit Cancer Surveillance System. Women with two or more concurrent health conditions were 2.2 times more likely than breast cancer cases without comorbidity to die from their breast cancer over a four-year period (95% CI: 1.13, 4.18). Limiting heart disease was especially problematic. Recommendations are made for future research in this area.

Keywords

Breast Cancer Comorbid Condition Breast Cancer Survival Invasive Breast Cancer Breast Cancer Case 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ries, L.A.G.; Hankey, B.F.; Edwards, B.K. (ed.) Cancer Statistics Review, 1973–87. Bethesda, MD: National Cancer Institute (NIH Publication No. 90-2789) (1990).Google Scholar
  2. 2.
    Kelsey, J.L. A review of the epidemiology of human breast cancer. Epid. Rev. 1:74 (1980).Google Scholar
  3. 3.
    Miller, A.B.; Bulbrook, R.D. The epidemiology and etiology of breast cancer. New England J. Med. 303:1246 (1980).CrossRefGoogle Scholar
  4. 4.
    Pitelka, D.R.; Unemori, E.N.; Field, M.F. Cell-cell and cell stroma interactions in metastasis. In: Rich, M.A., Hager, J.C., Furmanski, P. (eds.) Understanding Breast Cancer: Clinical and Laboratory Aspects. Dekker, New York. 99 (1984).Google Scholar
  5. 5.
    Bertuzzi, A.; Daidone, M.O.; DiFronzo, G.; Silverstrini, R. Relationship among estrogen receptors, proliferative activity and menopausal status in breast cancer. Breast Cancer Res. Treat. 1:253 (1981).PubMedCrossRefGoogle Scholar
  6. 6.
    Boyle, P.; Leake, R. Progress in understanding breast cancer: epidemiological and biological interactions. Breast Cancer Res. Treat. 11:91 (1988).PubMedCrossRefGoogle Scholar
  7. 7.
    Russo, J.; Frederick, J.; Ownby, H.E.; Fine, G.; Hussain, M.; Krickstein, H.I.; Robbins, T.O.; Rosenberg, B. Predictors of recurrence and survival of patients with breast cancer. Amer. J. of Clin. Path. 88:123 (1987).Google Scholar
  8. 8.
    Donegan, W.L.; Hartz, A.J.; Rimm, A.A. The association of body weight with recurrent cancer of the breast. Cancer 41:1590 (1978).PubMedCrossRefGoogle Scholar
  9. 9.
    Mohle-Boetani, J.; Grosser, S.; Whittemore, A.S.; Malec, M.; Kampert, J.B.; Paffenbarger, R.S. Body size, reproductive factors, and breast cancer survival. Prev. Med. 17:634 (1988).PubMedCrossRefGoogle Scholar
  10. 10.
    Charlson, M.E.; Pompei, P.; Ales, K.L.; MacKenzie, C.R. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chrorn. Dis. 40:373 (1987).CrossRefGoogle Scholar
  11. 11.
    Satariano, W.A.; Ragheb, N.E.; Dupuis, M.A. Comorbidity in older women with breast cancer: an epidemiologic approach. In: Yancik, R.; Yates, J. (eds.) Cancer in the Elderly: Approaches to Early Detection and Treatment. Springer, New York. 71 (1989).Google Scholar
  12. 12.
    Verbrugge, L.M.; Lepkowski, J.M.; Imanaka, Y. Comorbidity and its impact on disability. Milbank Q. 67:450 (1989).PubMedCrossRefGoogle Scholar
  13. 13.
    Berkman, L.F.; Breslow, L. Health and Ways of Living: The Alameda County Study. Oxford University, New York (1983).Google Scholar
  14. 14.
    Kaplan, G.A.; Camacho, T. Perceived health and mortality: A 9-year follow-up of the Human Population Laboratory cohort. Amer. J. Epid. 117:293 (1983).Google Scholar
  15. 15.
    Kaplan, G.A.; Kotler, P.L. Self-reports predictive of mortality from ischemic heart disease: A nine-year follow-up of the Human Population Laboratory cohort. J. Chron. Dis. 38:196 (1985).CrossRefGoogle Scholar
  16. 16.
    Wiley, J.A.; Camacho, T.c. Life-style and future health: evidence from the Alameda County Study. Prev. Med. 9:1 (1980).PubMedCrossRefGoogle Scholar
  17. 17.
    Bush, T.L.; Miller, S.R.; Golden, A.L.; Hale, W.E. Self-report and medical record agreement of selected medical conditions in the elderly. Amer. J. Publ. Health 79:1554 (1989).CrossRefGoogle Scholar
  18. 18.
    Centers for Disease Control Cancer and Steroid Study. Oral contraceptice use and the risk of endometrial cancer. J. Amer. Med. Assn. 49:1600 (1983).Google Scholar
  19. 19.
    Von Hoff, D.D.; Layard, M.W.; Basa, P.; Davis, H.L.; Von Hoff, A.L.; Rozencweig, M.; Muggia, F.M. Risk factors for doxorubicin-induced congestive heart failure. Ann. Intern. Med. 91:710 (1979).Google Scholar
  20. 20.
    Goates, R.J.; Clark, W.S.; Eley, J.W.; Greenberg, R.S.; Huguley, C.M.; Brown, R.L. Race, nutritional status, and survival from breast cancer. J. Nat. Cancer Inst. 82:1684 (1990).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • William A. Satariano
    • 1
  1. 1.School of Public HealthUniversity of California at BerkeleyBerkeleyUSA

Personalised recommendations